Skip to navigation menu Skip to content
Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Gastroenterology and Hepatology

Statistics and Outcomes

We treat the entire range of childhood and young adult conditions related to the liver and gastrointestinal system – including rare and complex diseases. We bring years of experience to your child’s unique situation.

Seattle Children’s Gastroenterology and Hepatology Program is the largest such program in the Washington, Wyoming, Alaska, Montana and Idaho (WWAMI) region.

Our Gastroenterology Program is one of the top-ranked programs of its kind in the United States, which means your child will be cared for by the very best.

  • What Seattle Children’s measures and why

    "Outcomes” refer to the results of treatment and evaluate how effective care is. We also provide statistics such as the number of patients seen (volumes). 

    We gather this data to:  

    • Measure the health of our patients
    • Improve the quality of the care we provide
    • Help you make informed decisions about your child’s care 

    Learn more about outcomes at Seattle Children’s.

Gastroenterology and Hepatology by the Numbers

24
Pediatric specialists, more than anywhere else in our region
52
Current clinical trials and research activities we participate in
83.50%
Patients with IBD in prednisone-free remission in 2024

Gastroenterology and Hepatology Patient Support

Dedicated Multidisciplinary Team Members

  • Patient care coordinators
  • Social workers
  • Psychologist
  • Registered nurses
  • Registered dietitians

Family and Patient Support Groups

  • IBD Support Group
  • Celiac Support Group
  • Intestinal Rehab Support Group
  • Special Diet Cooking Classes Cooking

Gastroenterology and Hepatology Procedure Volumes

Total number of endoscopic procedures and motility procedures, 2024

4,302

Endoscopic procedures include:

Colonoscopy; colostomy; rectum biopsy; upper and lower endoscopy (EGD); EGD with capsule; EGD with gastric banding; EGD with control bleeding; EGD with biopsy; EGD with PEG placement; EGD with Botox; EGD with button to button change; EGD with balloon dilation; EGD with AD catheter placement; ERCP; fecal transplant; fecal disimipaction; pouchoscopy; liver needle biopsy;  sigmoidoscopy flex biopsy; cystoscopy; ileoscopy; internal anal sphincter with Botox; gastrotomy closure

Motility procedures include:

Esophageal PH monitoring, anorectal manometry, esophageal manometry, ileal manometry, colon manometry

Gastroenterology and Hepatology Patient Volumes

Total number of gastroenterology outpatient visits, 2024

14,911

Number of patients treated in 2024, by disease

81
Biliary atresia (bile duct disease)
46
Celiac disease
479
Chronic liver disease
387
Eosinophilic esophagitis
932
Inflammatory bowel disease (IBD)
289
Intestinal rehabilitation
82
Portal hypertension

Pediatric Liver Transplants

Total number of liver transplants from May 1990 through 2024

373

Liver transplant survival rates

This table compares survival rates at Seattle Children’s with the national average for pediatric patients. Pediatric patients are children who are not yet 18 years old.

  • One-year patient survival
    97.14%
    Seattle Children’s 1-year patient survival
    95.28%
    National average 1-year patient survival
    35
    Number of patients transplanted at Seattle Children's
  • One-year graft survival
    97.30%
    Seattle Children’s 1-year graft survival
    92.90%
    National average 1-year graft survival
    37
    Number of grafts transplanted at Seattle Children's
  • Three-year patient survival
    100%
    Seattle Children’s 3-year patient survival
    92.67%
    National average 3-year patient survival
    23
    Number of patients transplanted at Seattle Children's
  • Three-year graft survival
    90.91%
    Seattle Children’s 3-year graft survival
    88.81%
    National average 3-year graft survival
    23
    Number of grafts transplanted at Seattle Children's

These data are for liver transplants performed in the following periods:

  • 1-year survival: Jul. 1, 2021 to Dec. 31, 2023
  • 3-year survival: Jan. 1, 2019 to Mar. 12, 2020 and Jun. 13, 2020 to Jun. 30, 2021.

Transplant data updated October 2024

Next SRTR update: July 2025

Where does this information come from?

These tables reflect metrics reported to the Scientific Registry of Transplant Recipients and the U.S. News & World Report pediatric hospital survey.

Who do I contact if I have questions?

Talk with your child’s doctor or contact the Gastroenterology and Hepatology Program at 206-987-2521.

Updated Sept. 2020